SCHEMBL1503635

SCHEMBL1503635

C[C@](CNC(=O)c1ccc(O)cc1)(C(=O)O)N1CCCCC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.49
ALDH1A1 P00352 3/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
PKM P14618 1/20 0.43
CNR1 P21554 2/20 0.42
CNR2 P34972 2/20 0.42
ESRRG P62508 2/20 0.42
ESRRB O95718 1/20 0.42
ADAM17 P78536 1/20 0.41
NPSR1 Q6W5P4 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
DPP4 P27487 1/20 0.39
PRSS1 P07477 1/20 0.39
CTSG P08311 1/20 0.39
CTRB1 P17538 1/20 0.39
CMA1 P23946 1/20 0.39
LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1503540 0.87 ALDH1A1 (0.53) ALDH1A1MEN1KMT2APKMCNR1
SCHEMBL1504684 0.84 ALDH1A1 (0.42) NPC1ALDH1A1MEN1KMT2APKM
SCHEMBL1503623 0.80 ALDH1A1 (0.46) NPC1ALDH1A1MEN1KMT2AADAM17
SCHEMBL1503688 0.79 ADAM17 (0.72) PKMADAM17HTT
SCHEMBL2681243 0.77 ALDH1A1 (0.43) ALDH1A1MEN1KMT2ALMNAMAPT
SCHEMBL1503654 0.77 ADAM17 (0.61) ALDH1A1ADAM17LMNA
SCHEMBL12077180 0.77 ADAM17 (0.60) NPC1ALDH1A1PKMCNR1CNR2
SCHEMBL24871621 0.73 ESRRG (0.55) NPC1ALDH1A1MEN1KMT2AESRRG
SCHEMBL18652186 0.73 ESRRG (0.55) NPC1ALDH1A1MEN1KMT2ACNR1
SCHEMBL6207632 0.71 CYP2D6 (0.54) ALDH1A1MEN1KMT2ANPSR1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011033010-A1 4-ALKOXY-N- (2-HYDROXYCARBAMOYL-2-PIPERIDINYL-ETHYL) -BENZAMIDE COMPOUNDS AS SELECTIVE TACE-INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASES GALDERMA RESEARCH & DEVELOPMENT (FR) 2011-03-24 WO disclosed